Furthermore, IL‐1β can promote the release of inflammatory cytokines by mediating pancreatic β‐cell apoptosis or activating the NF‐κB pathway, thereby inducing insulin resistance and the development of type 2 diabetes (Xue et al., 2005; Zhang & Kaufman, 2008). Here, IL1B is linked to type 2 diabetes mellitus.